From: Design and methods of the prevalence and pharmacogenomics of tenofovir nephrotoxicity in HIV-positive adults in south-western Nigeria study
Odds ratio
Sample Size (N)
1.25
2531
1.50
760
1.75
398
2.00
260
2.25
191
2.50
150
2.75
124
3.00
106